D-0570-2020 Class II Terminated
FDA drug recall D-0570-2020 was initiated by QuVa Pharma, Inc. on November 12, 2019 and is designated Class II. Reason for recall: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules The recall status is terminated (terminated June 5, 2020).
Recall Details
- Product Type
- Drugs
- Report Date
- December 11, 2019
- Initiation Date
- November 12, 2019
- Termination Date
- June 5, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL PCA Vial Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1180-79
Reason for Recall
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Distribution Pattern
Nationwide.
Code Information
Lots: 10030060 Exp. 11/21/2019, 10030574 Exp. 11/28/2019, 10031353 Exp. 12/12/2019, 10031677 Exp. 12/20/2019, 10031622 Exp. 12/19/2019, 10031419 Exp. 12/15/2019, 10031769 Exp. 12/26/2019, 10031826 Exp. 12/23/2019, 10032287 Exp. 12/30/2019